TORIPALIMAB for Transitional cell carcinoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 12 adverse event reports in the FDA FAERS database where TORIPALIMAB was used for Transitional cell carcinoma.

Most Reported Side Effects for TORIPALIMAB

Side Effect	Reports	%	Deaths	Hosp.
Myelosuppression	590	43.9%	3	432
Off label use	276	20.5%	29	137
White blood cell count decreased	144	10.7%	0	74
Anaemia	67	5.0%	17	8
Hypothyroidism	67	5.0%	13	11
Neutrophil count decreased	67	5.0%	0	25
Nausea	60	4.5%	7	14
Rash	59	4.4%	7	11
Vomiting	58	4.3%	7	14
Platelet count decreased	53	3.9%	3	30
Diarrhoea	50	3.7%	6	16
Neutropenia	49	3.7%	8	1
Thrombocytopenia	48	3.6%	12	0
Pyrexia	46	3.4%	2	13
Decreased appetite	43	3.2%	9	9